when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LEADING · news · pharmadog

← back to LEADING

News mentioning LEADING

652 stories

21dPfizer pens $500M Enodia pact to join Lilly in emerging protein degrader fieldfiercebiotech

21dOpinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionarystat

21dHengrui has become the go-to source of China biopharma innovation. What’s its secret?fiercebiotech

22dViatris boosts pain drug portfolio with $1.7B buyout of Pacirabiopharma dive

22dSTAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune diseasestat

22dA mother-daughter quest to find fellow members of an ultra-rare genetic communitystat

22dPhRMA sues Trump administration over GLOBE drug pricing demo programendpoints

23dCerevance Parkinson’s drug shortens 'off time' in Ph. 3, paving path to FDAbiospace

23dArriVent sheds nearly half of value on late-stage lung cancer missbiospace

23dSTAT+: Forbion raises $2.6 billion, its largest fundraise to datestat

23dGenmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, morebiospace

23d5 biggest venture capital raises of Q3 2026biospace

24dThe top biopharma conferences in 2027biopharma dive

24d[Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focusbiopharma dive

24dBioSpace 40 Under 40 winners make their mark on biopharmabiospace

24dNova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital Meterfda medwatch

24dUK unveils new policy to constantly monitor AI-based medical devicesfiercebiotech

25dOpinion: Energy drinks’ new college sports partnerships make them more dangerous than everstat

25dWeighing the risks of CAR T in autoimmune disease as Kyverna nears marketbiospace

25dWeighing the risks of CAR T in autoimmune disease as Kyverna nears marketbiospace

25dCSL pays $355M to co-develop Alentis’ phase 2-stage fibrosis drugfiercebiotech

25dGenmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elaherefiercebiotech

25dSwiss CDMOs and CROs ride a new wave of growth amid surge in global demandbiospace

27dGeographic atrophy biotech Aviceda to shut down after Phase 2 failendpoints

28dWhat it’s like to wait for the call from the Nobel Prize committeestat

28dThis week in charts: Kodiak’s big comeback and Hengrui’s dealmakingbiopharma dive

28dAccess to addiction meds for young people has improved — but retention hasn’tstat

28dKailera, Hengrui’s GLP-1/GIP candidate delivers weight, menstrual benefits to women with PMOSbiospace

28dNovartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s Abogenbiospace

28dAbbott launches SimpleScreen CRC blood test in the USfiercebiotech

← prevpage 4 of 22next →